Woodline Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Woodline Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	+27,075	New	+$862K	﹤0.01%	902
2025 Q4	–	Sell	-74,571	Closed	-$2.07M	–	1021
2025 Q3	$2.07M	Buy	+74,571	New	+$1.88M	0.01%	729
2025 Q2	–	Sell	-62,368	Closed	-$1.29M	–	923
2025 Q1	$1.29M	Sell	62,368 -16,862	-21%	-$424K	0.01%	730
2024 Q4	$1.87M	Buy	+79,230	New	+$1.95M	0.01%	663

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Woodline Partners's ARKG Position: Q2 2026 in Review

Woodline Partners opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 27,075 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #902 among its holdings. This is a return to the name: Woodline Partners previously reported a position in ARKG as recently as Q3 2025.

Woodline Partners first reported a position in ARKG in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.07M in Q3 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Woodline Partners held 27,075 shares of ARK Genomic Revolution ETF worth $1.14M as of Q2 2026.
ARK Genomic Revolution ETF was a new Woodline Partners position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #902 holding.
Woodline Partners first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 4 quarters since.
Woodline Partners's ARK Genomic Revolution ETF position peaked at $2.07M in Q3 2025.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.